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Abstract
Background: Isoexpansile concentrations of intraocular gases are typically used as tamponading agent in macular
hole surgery. Using a small volume of the pure form of these gases may achieve the same result without increasing
the incidence of postoperative complications. The purpose of this study was to evaluate the anatomical and visual
outcomes following macular hole surgery with 2 cc pure (100 %) sulfur hexafluoride (SF6) gas tamponade.
Methods: A retrospective study of eyes with idiopathic macular holes that underwent 23-gauge pars plana
vitrectomy with 2 cc pure SF6 gas tamponade. Macular hole surgery was performed alone or in combination
with phacoemulsification in eyes with cataract. Preoperative and postoperative data including best corrected
visual acuity recorded in LogMAR units, slit-lamp biomicroscopy, and optical coherence tomography were analysed.
Surgical complications were also recorded.
Results: Seventy six eyes of seventy five patients were analysed. A closure rate of 100 % was achieved with
reoperation in 4 eyes. There was a significant improvement in best-corrected visual acuity from a mean of 0.65
LogMAR preoperatively to 0.36 at 6 months (p value 0.004). Forty five (59 %) eyes gained at least 2 lines on the
Snellen visual acuity chart. Postoperative elevation in intraocular pressure (≥30 mmHg) was documented in 3
eyes (4 %).
Conclusion: Macular hole surgery with 2 cc pure SF6 gas tamponade achieved a high success rate with a low
incidence of complications. The smaller volume of gas required makes it a cheaper technique.
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Background
Recent advances in surgical techniques and instrumenta-
tion have made Macular Hole Surgery (MHS) now one
of the most successful and gratifying procedures for
vitreoretinal surgeons [1]. The first report of MHS was
published in 1991 by Kelly and Wendel who achieved a
58 % closure rate in 52 operated eyes [2]. Today,
however, success rates of over 90 % have been recorded
[3–7]. Macular hole surgery typically involves Pars Plana
Vitrectomy (PPV), Internal Limiting Membrane (ILM)
peeling and internal gas tamponade [8]. The commonly
used gases are Sulfur Hexafluoride (SF6) and Perfluoro-
propane (C3F8) with the shorter acting SF6 being pre-
ferred by Japanese and American retinal surgeons [9,
10]. Sulfur hexafluoride achieves similar results to C3F8
and is absorbed faster, allowing for quicker visual re-
habilitation [6].
When used to fill the posterior segment during sur-
gery, intraocular gases are usually diluted with air be-
cause of the tendency of the pure forms of these gases
to expand within the eye [9]. A recent survey of the
American Society of Retina Specialists (ASRS) revealed
that 90 % of respondents used a full gas fill with an iso-
expansile mixture, 9 % used injection of pure gas into an
estimated eye volume to achieve a desired concentration,
and 1 % manually diluted pure gas in a large syringe
during air-gas exchange. When using pure SF6 or C3F8 a
volume must be chosen so that subsequent expansion of
the gas does not result in a dangerous elevation of Intra-
ocular Pressure (IOP) [11]. The aim of this study was to
assess the anatomical and visual outcomes with 2 cc
pure SF6 gas tamponade for MHS.* Correspondence: korexmed@yahoo.com1Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, 1 Anna
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Methods
This was a retrospective case series involving eyes with
macular holes that underwent MHS with 2 cc pure
(100 %) SF6 gas tamponade at Aravind Eye Hospital in
Madurai, India. The study adhered to the tenets of the
declaration of Helsinki and was approved by the
Institutional Review Board of the hospital (IRB number:
20122016CLI). Surgeries were carried out over a period
of 32 months from July 2011 to February 2014. Inclusion
criteria included eyes with idiopathic stage 2–4 macular
holes and postoperative follow-up of at least 6 months
duration. Exclusion criteria were eyes with traumatic
macular holes, high myopia (≥ minus 6D), previous PPV
and co-existing ocular co-morbidity such as retinal de-
tachment, glaucoma or diabetic retinopathy.
Demographic data including age and gender were ob-
tained for each patient as well as duration of symptoms
and involved eye. Preoperative evaluation included Best-
Corrected Visual Acuity (BCVA) assessment with the
Snellen Visual Acuity (VA) chart, slit lamp examination
of the anterior segment, IOP measurement and a dilated
fundus examination. A macular hole was diagnosed by
slit lamp biomicroscopy with a 90D lens and confirmed
by Spectral Domain Optical Coherence Tomography
(Spectralis HRA +OCT by Heidelberg Engineering,
Heidelberg, Germany). The basal diameter of the macu-
lar hole was measured on OCT in all cases.
Macular hole surgery was performed with or without
phacoemulsification. A written informed consent was
obtained from each patient prior to surgery. Combin-
ation with phacoemulsification was done if a cataract
was present. Surgeries were done under peribulbar local
anaesthesia. Phacoemulsification with implantation of an
acrylic foldable Intraocular Lens (IOL) in the capsular
bag was done by a cataract surgeon just before the MHS
in cases of combined surgery. Cataract surgeries were
performed by more than one surgeon while all the
macular hole surgeries were carried out by a single expe-
rienced surgeon. A PPV with 23-gauge, standard 3-port
approach was done in each case. Central core vitrectomy
was performed followed by detachment of the posterior
hyaloid (for stage 2 and 3 macular holes) using high vac-
uum of the vitrectomy probe and assisted by intravitreal
triamcinolone injection. The peripheral vitreous was
then removed with careful inspection of the retinal per-
iphery. The macular area was stained with brilliant blue
G dye 0.05 % (Ocublue plus by Aurolab, India) and peel-
ing of the ILM carried out. Where an epiretinal mem-
brane was present it was removed before peeling the
ILM. A complete fluid-air exchange was performed and
the superonasal and superotemporal cannulae removed
and the conjunctiva repositioned to cover the sclerotomy
sites. Injection of 2 cc pure SF6 with a 30-gauge needle
inserted through the pars plana superiorly was then
done with the air-infusion line used for venting. After
the syringe was flushed, the infusion line was clamped
and the digital tension of the globe assessed. The infu-
sion cannula was then removed and the inferotemporal
sclerotomy sealed. Patients were advised to maintain a
face-down position for 7 days.
Postoperatively topical steroids, antibiotics and cyclo-
plegics were prescribed and gradually tapered. Patients
were examined on day 1, at 2 weeks, 6 weeks, 3 months
and then at 6 months postoperatively. Gas fill of the eye
and IOP were assessed on the first postoperative day
and at 2 weeks. Best-corrected visual acuity and IOP
were measured at each visit and a slit lamp biomicro-
scopy with a 90D lens done to assess the status of the
hole. Postoperative complications were documented
when present. All the patients had an OCT done at
2 weeks to confirm the status of the hole.
Data analysis was done using Epi Info 7.1.5.0. Best-
corrected visual acuity was recorded as a Snellen visual
acuity and converted to LogMAR for statistical analysis.
Frequencies and percentages were computed for qualita-
tive variables like gender, stage of macular hole, and pre-
operative lens status. Mean and standard deviation was
computed for quantitative variables such as age, macular
hole diameter, BCVA and IOP. Tests for statistical sig-
nificance were done using Mann-Whitney/Wilcoxon
two-sample test (Kruskal-Wallis test for two groups). A
p-value of less than 0.05 was considered statistically sig-
nificant. Visual improvement was defined as an increase
in BCVA by 2 or more lines on the Snellen VA chart at
6 months follow-up while anatomical success was de-
fined as hole closure on OCT. The primary outcome
measures were anatomical success and visual improve-
ment while secondary outcome was postoperative com-
plications. At follow-up, macular holes were categorized
as either open or, if closed, as type 1 or type 2 as earlier
described by Kang et al [12]. Type 1 closure refers to
closure of the macular hole without foveal defect of the
neurosensory retina while type 2 closure indicates a per-
sistent foveal defect of the neurosensory retina even
though the whole rim of the macular hole is attached to
the underlying retinal pigment epithelium with flattening
of the cuff.
Results
A total of 76 consecutive eyes of 75 patients met the
study criteria and were analysed. One patient had bilat-
eral surgery. These were made up of 33 males (44 %)
and 42 females (56 %) giving a male:female ratio of 1:1.3.
The mean age of the patients was 61.8 years (SD 5.6).
Sixty three eyes were phakic (83 %) and 13 eyes pseudo-
phakic (17 %). The clinical characteristics of the macular
holes and stages are shown in Tables 1 and 2. Forty nine
eyes (64.5 %) with varying degrees of immature cataracts
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had phacoemulsification in combination with MHS.
These constituted 78 % of the phakic eyes.
Mean intraocular gas bubble size on the first post-
operative day was 73 % (SD 6.1) with a range of 50–
90 %. The gas bubble had completely absorbed by the
first postoperative visit at 2 weeks in all the eyes.
Closure of the hole was achieved at first surgery in
72 eyes (94.7 %). Seventy eyes (92 %) had a type 1
closure while 2 eyes (2.6 %) with large holes had a
type 2 closure (Fig. 1). Four eyes in which the hole
remained open postoperatively at 2 weeks had a reop-
eration with fluid-air exchange followed by injection
with 2 cc pure SF6. The hole was successfully closed
in each case. Anatomical success was therefore
achieved in 94.7 % of eyes at first surgery and in
100 % with resurgery.
There was a statistically significant improvement in
BCVA from a mean of 0.65 LogMAR preoperatively to
0.36 (p value 0.004) at 6 months. Sixty eyes (79 %) had
an improvement in vision with 45 eyes (59 %) gaining at
least 2 lines on the Snellen VA chart. Fourteen eyes
(18 %) had no change in BCVA while 2 (2.6 %) eyes lost
a line. The mean improvement in Snellen acuity was
1.86 lines (SD 1.36).
There were no intraoperative complications. A mild
increase in mean IOP from 14.8 mmHg preoperatively
to 16.23 mmHg on the first postoperative day was ob-
served. This difference was statistically significant with a
p value of 0.01. Three (4 %) eyes had elevated IOP
(≥30 mmHg) and were prescribed topical antiglaucoma
medications with the IOP returning to normal in 2 eyes
at the first follow-up visit at 2 weeks. The third patient
had severe postoperative anterior segment inflammation
following combined surgery and had to be on treatment
for 6 weeks. No case of ocular hypotony was recorded.
One patient developed a visually significant cataract
4 months after surgery and underwent phacoemulsifica-
tion with IOL implantation. No other long term compli-
cations were encountered. The raw data for this study is
available as Additional file 1.
Discussion
Since the first report of successful closure of idiopathic
macular holes with PPV and fluid-gas exchange in 1991
[2], there have been several modifications made to im-
prove surgical outcomes. Macular hole surgery requires
internal gas tamponade and a range of gas types and
mixtures have been used with good success [6]. The in-
traocular gas provides isolation or waterproofing of the
macular hole from the vitreous cavity by surface-tension
at the gas-liquid interface. It also mechanically tampo-
nades the hole and provides a template over which a
nascent bridging membrane forms [13]. In this study, we
achieved a closure rate of 100 % with 2 cc pure SF6 gas
tamponade. This compares favourably with results ob-
tained with isoexpansile gas mixtures [3–7]. Peeling of
the ILM is a likely contributor to this excellent closure
rate as it has been shown to significantly improve ana-
tomic success in all stages of chronic and recent macular
holes as well as in macula hole retinal detachments [3,
14, 15]. It is believed to facilitate macular hole closure
by removing an element of traction or by stimulating
gliosis [6].
Intraocular gas volume on the first postoperative day
is an important index of postoperative gas dynamics be-
cause less gas volume would lead to insufficient tampon-
ade to the retina [16]. A gas bubble size of 73 %
obtained on the first postoperative day in this study is
lower than 83.8 % reported by Kusuhara et al [16] with
25 % SF6. Eyes treated with 23-gauge transconjunctival
vitrectomy tend to have earlier gas disappearance or in-
complete gas fill as a result of postoperative gas leakage
through unsutured sclerotomies. After MHS, however,
the most important feature of the gas bubble is its sur-
face tension, which leads to closure of the hole by keep-
ing its edge dry, independent of buoyancy [17]. The
surface tension represents contact around the entire
interface with the retina [17]. A gas bubble size of 75 %
will make an arc of contact with the retina of 2400 [18].
Another important factor in gas bubble dynamics which
is required to maintain a therapeutic effect after surgery
is the interval it takes for the gas to dissipate to a 50 %
gas fill (Gas50). This has been used as an index of early
postoperative decrease in intraocular gas volume and
postoperative gas longevity [16]. Twenty three-gauge
PPV which was used in this series is associated with a
shorter Gas50 than 20-gauge PPV [16]. Though the
Gas50 was not measured in this study, the excellent
closure rate suggests that the average gas bubble size of
73 % obtained with 2 cc SF6 on the first postoperative
day, as well as the duration of the gas bubble were suffi-
cient to accomplish hole closure.
The aim of MHS is to improve the patient’s vision and
prevent further visual deterioration [19]. In this present
series there was a significant improvement in
Table 1 Macular hole characteristics
Mean Range
Duration of macular hole (months) 4.5 ± 2.5 0.3–12
Hole size (μm) 523.68 ± 233 234–1802
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postoperative vision. This is in agreement with previous
studies [3, 4, 6, 17]. The mean postoperative BCVA of
LogMAR 0.36 in this series is slightly better than 0.49
obtained by Kim et al [6]. This difference is due to the
better preoperative BCVA in this study. Preoperative vis-
ual acuity is one of the most important prognostic fac-
tors for a good visual outcome following MHS with eyes
having a good preoperative visual acuity more likely to
attain a better postoperative visual acuity [19, 20]. The
proportion of eyes in this study that improved by at least
2 lines on the Snellen chart (59 %) was, however, lower
than over 70 % reported by other authors [21, 22].
Several complications may occur with intraocular gas
tamponade such as increased IOP, inadequate bubble
size, cataract formation, visual field defects, retinal
breaks and proliferative vitreoretinopathy [13]. The main
concern on day 1, however, is raised IOP and the risk of
this occurring has been estimated to be 20–21 % [23].
The increase is usually transient occurring in the major-
ity of eyes within 24 h of surgery and can be managed
with topical or systemic anti-glaucoma agents [13, 24].
In a survey on the use of long-lasting expanding gases in
ophthalmology in Japan, IOP rise was the most common
complication occurring in 15 % of cases involving PPV
with the use of expansile gases [25]. The incidence of
significant IOP spike with 2 cc SF6 in this present study
was 4 % which is lower than 13 % reported by Xirou and
colleagues [21] using 20-gauge instruments and
isoexpansile gas tampomade. Heath and Rahman [26],
however, did not record this complication in their series
with 23-gauge PPV. Studies have shown that mean post-
operative IOP on day 1 as well as the incidence of IOP
spike are higher following 20-gauge PPV compared with
23-gauge PPV [15, 27, 28]. Hypotony on the other hand
is more likely with sutureless 23-gauge vitrectomy [15,
27, 28]. Hypotony was not encountered in this current
series.
One case of visually significant cataract was docu-
mented postoperatively in this study. The incidence of
this complication was very low as majority of the pa-
tients either had combined surgery or had previously
undergone cataract extraction. Cataract progression or
formation may result from oxidative stress to the lens
and trauma following vitrectomy [13]. Prolonged contact
of the intraocular gas with the posterior lens surface can
also lead to gas-induced cataract, presenting typically as
‘lens feathering’, a manifestation of the branching pattern
of posterior subcapsular lens changes [13].
Using 2 cc pure SF6 as gas tamponade for MHS has
some advantages over the non-expansile concentration
of the gas. First is that a smaller volume of the gas is re-
quired making this technique cost effective. When using
a 20 cc syringe to flush a non-expansile concentration of
20 % SF6 gas following fluid-air exchange, 4 cc of SF6
will be required and more if a 50 cc syringe is used. Sec-
ondly, no cumbersome calculations are required to
Fig. 1 OCT of type 2 macular hole closure. a Preoperative OCT. b Postoperative OCT
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calculate the volume of gas needed. The chances of er-
rors occurring are, therefore, much less.
The limitations of this study include its retrospective
nature, lack of a control group and the relatively small
number of cases analysed. Our excellent results, how-
ever, provide useful data that could aid in the planning
of further prospective, randomized clinical studies such
as the outcome of this technique with smaller gauge in-
struments. The use of smaller volumes of other expan-
sile gases such as C3F8 in MHS can also be studied.
Conclusion
In conclusion, 2 cc pure SF6 gas tamponade for MHS
achieved excellent results with a low incidence of com-
plications. It is a simple technique as no calculations are
required to determine the volume of gas to be injected.
The smaller volume of gas required compared with
using a non-expansile concentration also makes it cost
effective.
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